Find a TenderAwarded without competition
Published 31 Aug 2021, 17:07 BST

Official UK procurement notice

Provision of Seegene rapid in-house SARS CoV 2 Testing System and Variant of Concern (VOC) testing

Official notice

Authority: Belfast Health and Social Care Trust (Central government)

GoodsAward procedure without prior publication of a call for competition
Awarded value£300,000published contract · exc. VAT
Awarded 21 Sept 2021no call for competition
Awarded to Accuscience Limited2 awards

What is being bought

Published requirement description

Provision of Seegene rapid in-house SARS CoV 2 Testing System and Variant of Concern (VOC) testing

CPV: Laboratory, optical and precision equipments (excl. glasses)

The lotProcurement structure

single lot · no lot value published
Lot #1Awarded
Delivery: Northern Ireland · Belfast Health and Social Care Trust

Procedure terms & legal framework

From the official record
Procedure method
Award procedure without prior publication of a call for competition
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Goods
Notice status
Awarded without competition
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Direct award (no call for competition)
GPA / WTO covered
Yes (GPA)
Recurring procurement
Unspecified in notice
First published
31 Aug 2021, 17:07 BST
Last source update
4 Oct 2021, 15:07 BST
Authority reference
DAC10068
FTS notice number
2021/S 000-024621
Classification (CPV)
Laboratory, optical and precision equipments (excl. glasses)
Delivery area
Northern Ireland (UKN)
Official registry OCID
ocds-h6vhtk-02db6b Find a Tender
Why no open competition

The works, supplies or services can be provided only by a particular economic operator due to absence of competition for technical reasons; Additional deliveries by the original supplier ordered under the strict conditions stated in the directive

Published justification

No reasonable alternative exists for this procurement, it is in the public interest and is required to enable the Regional Virology Laboratory to meet Covid-19 surge testing requirements. The absence of competition is not a result of the artificial narrowing of the parameters of the procurement

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Awards 2
Awarded value £300,0001 contract exc. VAT · 1 repeated publication of the same award counted once
Bids received 1
Contracts signed 2latest 21 Sept 2021
Awarded toValueDateStatus
Accuscience Limited£300,000 †same award published again · counted once—Awarded
Accuscience Limited£300,000 †—Awarded

Contracts

  • Provision of Seegene rapid in-house SARS CoV 2 Testing System and Variant of Concern · Accuscience Limited

    Signed
    21 Sept 2021
    Value
    £300,000
    Status
    active
  • Provision of Seegene rapid in-house SARS CoV 2 Testing System and Variant of Concern (VOC) testing · Accuscience Limited

    Signed
    31 Aug 2021
    Value
    £300,000
    Status
    active

Bid statistics published by the authority

BidsSMEVCSEValid bid range
1bids———

Contracting authority & participating public bodies

BELFAST HEALTH AND SOCIAL CARE TRUST

Contracting authorityCentral GovernmentBody governed by public lawHealth LISBURN ROAD, BELFAST, Northern Ireland, BT97ABContact name, email

Dispute resolution & review bodies

  • Belfast Health & Social Care TrustReview body BelfastContact email

Bidders & participating suppliers

2 commercial parties on the notice

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.